Background: Docosahexaenoic acid (DHA) is amajor constituent of neuronal and retinal membranes and plays a crucial role in brain and visual development within the first months of life. Dietary intakes are fundamental to provide neonates with adequate DHA supply; hence, maternal supplementation might represent a useful strategy to implement DHA contents in breast milk (BM), with possible benefits on neonatal neurodevelopment. Antarctic krill is a small crustacean rich in highly available phospholipid-bound DHA. This pilot study aimed to evaluate whether maternal supplementation with krill oil during breastfeeding increases long-chain polyunsaturated fatty acids (LCPUFAs) BM contents.Methods: Mothers of infants admitted to the Neonatal Intensive Care Unit were enrolled in this open, randomized-controlled study between 4 and 6 weeks after delivery and randomly allocated in 2 groups. Group 1 received an oral krill oil-based supplement providing 250mg/day of DHA and 70mg/day of eicosapentaenoic acid (EPA) for 30 days; group 2 served as control. BM samples from both groups were collected at baseline (T0) and day 30 (T1) and underwent a qualitative analysis of LCPUFAs composition by gas chromatography/mass spectrometry.Results: Sixteen breastfeeding women were included. Of these, 8 received krill-oil supplementation and 8 were randomized to the control group. Baseline percentage values of DHA (% DHA), arachidonic acid (% AA), and EPA (% EPA) did not differ between groups. A significant increase in % DHA (T0: median 0.23% [IQR 0.19; 0.38], T1: 0.42%[0.32; 0.49], p 0.012) and% EPA (T0: median 0.10%[IQR 0.04; 0.11], T1: 0.11% [0.04; 0.15], p 0.036) and a significant reduction in % AA (T0: median 0.48% [IQR 0.42; 0.75], T1: 0.43% [0.38; 0.61], p 0.017) between T0 and T1 occurred in Group 1, whereas no difference was seen in Group 2. Consistently, a significant between-group difference was observed in percentage changes from baseline of DHA (Delta% DHA, group 1: median 64.2% [IQR 27.5; 134.6], group 2: -7.8% [-12.1;-3.13], p 0.025) and EPA (Delta% EPA, group 1: median 39% [IQR 15.7; 73.4]; group 2: -25.62% [-32.7;-3.4], p 0.035).Conclusions: Oral krill oil supplementation effectively increases DHA and EPA contents in BM. Potential benefits of this strategy on brain and visual development in breastfed preterm neonates deserve further evaluation in targeted studies.

Maternal Supplementation With Krill Oil During Breastfeeding and Long-Chain Polyunsaturated Fatty Acids (LCPUFAs) Composition of Human Milk: A Feasibility Study

Cimatti, Anna Giulia;Martini, Silvia;Munarini, Alessandra;Vitali, Francesca;Aceti, Arianna;Faldella, Giacomo;Corvaglia, Luigi
2018

Abstract

Background: Docosahexaenoic acid (DHA) is amajor constituent of neuronal and retinal membranes and plays a crucial role in brain and visual development within the first months of life. Dietary intakes are fundamental to provide neonates with adequate DHA supply; hence, maternal supplementation might represent a useful strategy to implement DHA contents in breast milk (BM), with possible benefits on neonatal neurodevelopment. Antarctic krill is a small crustacean rich in highly available phospholipid-bound DHA. This pilot study aimed to evaluate whether maternal supplementation with krill oil during breastfeeding increases long-chain polyunsaturated fatty acids (LCPUFAs) BM contents.Methods: Mothers of infants admitted to the Neonatal Intensive Care Unit were enrolled in this open, randomized-controlled study between 4 and 6 weeks after delivery and randomly allocated in 2 groups. Group 1 received an oral krill oil-based supplement providing 250mg/day of DHA and 70mg/day of eicosapentaenoic acid (EPA) for 30 days; group 2 served as control. BM samples from both groups were collected at baseline (T0) and day 30 (T1) and underwent a qualitative analysis of LCPUFAs composition by gas chromatography/mass spectrometry.Results: Sixteen breastfeeding women were included. Of these, 8 received krill-oil supplementation and 8 were randomized to the control group. Baseline percentage values of DHA (% DHA), arachidonic acid (% AA), and EPA (% EPA) did not differ between groups. A significant increase in % DHA (T0: median 0.23% [IQR 0.19; 0.38], T1: 0.42%[0.32; 0.49], p 0.012) and% EPA (T0: median 0.10%[IQR 0.04; 0.11], T1: 0.11% [0.04; 0.15], p 0.036) and a significant reduction in % AA (T0: median 0.48% [IQR 0.42; 0.75], T1: 0.43% [0.38; 0.61], p 0.017) between T0 and T1 occurred in Group 1, whereas no difference was seen in Group 2. Consistently, a significant between-group difference was observed in percentage changes from baseline of DHA (Delta% DHA, group 1: median 64.2% [IQR 27.5; 134.6], group 2: -7.8% [-12.1;-3.13], p 0.025) and EPA (Delta% EPA, group 1: median 39% [IQR 15.7; 73.4]; group 2: -25.62% [-32.7;-3.4], p 0.035).Conclusions: Oral krill oil supplementation effectively increases DHA and EPA contents in BM. Potential benefits of this strategy on brain and visual development in breastfed preterm neonates deserve further evaluation in targeted studies.
FRONTIERS IN PEDIATRICS
Cimatti, Anna Giulia; Martini, Silvia; Munarini, Alessandra; Zioutas, Maximilano; Vitali, Francesca; Aceti, Arianna; Mantovani, Vilma; Faldella, Giacomo; Corvaglia, Luigi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11585/654882
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact